Related Experiment Videos
Postcardiotomy assisted circulation with roller pump--early and late results
D Nezić1, A Knezević, M Cirković
1Dedinje Cardiovascular Institute, Belgrade.
Acta Chirurgica Iugoslavica
|August 17, 2004
Summary
Post-heart surgery heart failure (PMF) is rare but serious. A roller pump left ventricular assist device (LVAD) provided short-term support, showing efficiency and comparable survival rates to other devices.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biomedical Engineering
Background:
- Postcardiotomy myocardial failure (PMF) occurs in 0.2% to 1.2% of cardiac surgery patients.
- Mechanical circulatory support beyond Intra-Aortic Balloon Pump (IABP) is crucial for severe PMF.
- Left Ventricular Assist Devices (LVADs) offer a potential solution for these critically ill patients.
Purpose of the Study:
- To evaluate the efficacy and outcomes of using a roller pump-driven LVAD for short-term circulatory support in patients with PMF.
- To assess the survival rates and functional status of patients treated with this LVAD configuration.
Main Methods:
- A retrospective analysis of 18 patients who received a roller pump LVAD for PMF between December 1989 and December 1995.
- Assisted flow rates ranged from 3.5 to 5 L/min, with an average support duration of 35.5 hours.
- Patient outcomes including in-hospital mortality, causes of death, hospital discharge, and long-term survival were analyzed.
Main Results:
- Six patients (33.3%) died while on LVAD support.
- Among patients weaned from LVAD, seven additional deaths occurred due to myocardial failure (4), stroke (2), and bleeding (1).
- Five patients (27.8%) were successfully discharged, with a 7-year actuarial survival rate of 60% in this group, all in NYHA functional class II.
Conclusions:
- Roller pump-driven LVADs are effective for short-term circulatory support in patients with postcardiotomy myocardial failure.
- Outcomes are comparable to existing data for similar devices, suggesting a viable treatment option.
- Long-term survivors demonstrated sustained functional capacity, highlighting the potential benefit of LVAD support in select PMF patients.